Spire Wealth Management Amphastar Pharmaceuticals, Inc. Transaction History
Spire Wealth Management
- $3.13 Billion
- Q4 2024
A detailed history of Spire Wealth Management transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 202 shares of AMPH stock, worth $7,373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
202
Previous 202
-0.0%
Holding current value
$7,373
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
36.5MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$99 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$77.9 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$71.1 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$59 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.79B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...